WANBURY
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Wanbury along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.64₹ 6.35
As on Dec 4, 2025, 3:40 PM IST
Wanbury Price Performance
Today's LowToday's High
₹234.45₹250.85
₹246.60
52 Weeks' Low52 Weeks' High
₹154.01₹329.70
₹246.60
Open Price
₹238.05
Prev. Close
₹240.25
Volume
4,372
Over the last 5 years, the share price of Wanbury has gained 46.57% CAGR. Over the past year, the corresponding return has been -7.42%.
Wanbury’s current P/E of 19.99x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Wanbury Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Wanbury | -2.53 | -7.72 | -11.71 | -17.35 | -7.55 | 71.40 | 46.53 |
| Sun Pharmaceutical Industries | 0.15 | 7.06 | 14.53 | 8.82 | 0.67 | 20.43 | 26.08 |
| Divi's Laboratories | -0.55 | -5.07 | 5.19 | -2.47 | 3.13 | 24.18 | 11.69 |
| Torrent Pharmaceuticals | 0.98 | 5.47 | 4.90 | 20.33 | 12.63 | 32.60 | 23.14 |
| Cipla | -0.63 | 0.76 | -3.97 | 2.91 | 0.93 | 10.74 | 14.60 |
| Dr. Reddy's Laboratories | 1.96 | 6.18 | 1.72 | 1.82 | 4.89 | 12.48 | 5.37 |
| Lupin | 0.91 | 4.66 | 7.83 | 7.63 | -0.49 | 39.52 | 17.52 |
| Zydus Lifesciences | 0.02 | -3.64 | -7.37 | 0.65 | -3.39 | 31.40 | 14.75 |
| Mankind Pharma | -1.75 | -6.74 | -13.89 | -5.84 | -14.92 | 15.77 | 9.18 |
| Aurobindo Pharma | -1.15 | 6.17 | 18.04 | 7.32 | -2.87 | 37.93 | 6.31 |
| Alkem Laboratories | -0.52 | -0.04 | 6.77 | 16.35 | -0.10 | 22.03 | 14.68 |
| Abbott India | -1.67 | -1.39 | -10.06 | -7.43 | 0.42 | 13.02 | 13.69 |
| Glenmark Pharmaceuticals | 1.65 | 6.95 | -0.79 | 30.35 | 27.60 | 65.54 | 31.46 |
| Laurus Labs | 0.57 | 2.76 | 15.66 | 62.09 | 73.13 | 33.92 | 24.95 |
| Biocon | -3.33 | 1.58 | 8.22 | 14.87 | 1.71 | 11.47 | -2.68 |
| GlaxoSmithKline Pharmaceuticals | -0.36 | -5.69 | -11.64 | -26.77 | 4.51 | 23.27 | 10.09 |
| Ipca Laboratories | 4.81 | 12.79 | 9.17 | 4.53 | -1.90 | 19.11 | 5.33 |
| Anthem Biosciences | 5.00 | -6.28 | -21.99 | -9.85 | -9.85 | -3.40 | -2.05 |
| Ajanta Pharma | 3.01 | -0.13 | 0.26 | 0.81 | -12.76 | 27.37 | 19.67 |
| Gland Pharma | -1.63 | -8.80 | -7.57 | 7.44 | -3.11 | -0.15 | -4.36 |
Over the last one year, Wanbury has declined 7.55% compared to peers like Sun Pharmaceutical Industries (0.67%), Divi's Laboratories (3.13%), Torrent Pharmaceuticals (12.63%). From a 5 year perspective, Wanbury has outperformed peers relative to Sun Pharmaceutical Industries (26.08%) and Divi's Laboratories (11.69%).
Wanbury Financials
Wanbury Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 248.39 | 246.58 |
| 10 | 239.22 | 244.96 |
| 20 | 244.1 | 244.29 |
| 50 | 246.64 | 248.06 |
| 100 | 256.85 | 253.1 |
| 200 | 254.75 | 250.91 |
Wanbury Share Holding Pattern
In the latest quarter, Wanbury saw a rise in promoter holding to 79.26%, while DII stake unchanged at 0.00%, FII holding fell to 0.80%, and public shareholding moved up to 59.55% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Wanbury Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 24, 2025, 7:48 PM IST | Wanbury - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 18, 2025, 11:01 PM IST | Wanbury - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 14, 2025, 1:27 AM IST | Wanbury - Announcement under Regulation 30 (LODR)-Allotment |
| Nov 14, 2025, 12:56 AM IST | Wanbury - Outcome Of The Board Meeting Held On November 13, 2025 |
| Nov 14, 2025, 12:50 AM IST | Wanbury - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 13, 2025 |
About Wanbury
Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 599.51 Cr. and Equity Capital is Rs. 32.77 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBSEL Tech Park, B-Wing, 10th Floor, Sector 30-A, New Mumbai Maharashtra 400703
- Contact
Management
- Mr. K ChandranWhole Time Director
- Mr. Mohan Kumar RayanaWhole Time Director
- Ms. Anupama VaidyaInd. Non-Executive Woman Director
- Mr. Mridul Sumanlal MehtaInd. Non-Executive Director
- Mr. P V Sankar DassInd. Non-Executive Director
- Mr. Manojkumar K GursahaniInd. Non-Executive Director
FAQs on Wanbury Share Price
What is the share price of Wanbury?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Wanbury is ₹246.60 as on Dec 04, 2025.
What kind of stock is Wanbury?
The Wanbury is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Wanbury?
The market cap of Wanbury is ₹859.22 Cr as on Dec 04, 2025.
What are today's High and Low prices of Wanbury?
Today’s highest and lowest price of Wanbury are ₹250.85 and ₹234.45.
What are the 52 Week High and 52 Week Low of Wanbury?
The 52-week high/low is the highest and lowest price at which Wanbury stock has traded in the past 52-week or nearly a year. The 52-week high of Wanbury is ₹329.70 and 52-week low of Wanbury is ₹154.01 as on Dec 04, 2025.
How has the Wanbury performed historically in terms of returns?
The Wanbury has shown returns of 2.64% over the past day, -7.59% for the past month, -11.58% over 3 months, -7.42% over 1 year, 71.49% across 3 years, and 46.57% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Wanbury?
P/E ratio of and PB ratio of Wanbury are 19.99 and 21.02 on Dec 04, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse